Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]

Affiliations

¹ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
² Hebei University of Chinese Medicine, College of Integrated Chinese and Western Medicine, China.
³ Technology Centre, Guangzhou Customs, China.
⁴ KingMed Virology Diagnostic & Translational Center, China.
⁵ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, China; KingMed Virology Diagnostic & Translational Center, China. Electronic address: jeffyah@163.com.

Published Erratum

Li Runfeng et al. Pharmacol Res. 2021 Dec.

. 2021 Dec:174:105907.

doi: 10.1016/j.phrs.2021.105907. Epub 2021 Nov 19.

¹ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China.
² Hebei University of Chinese Medicine, College of Integrated Chinese and Western Medicine, China.
³ Technology Centre, Guangzhou Customs, China.
⁴ KingMed Virology Diagnostic & Translational Center, China.
⁵ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, China; KingMed Virology Diagnostic & Translational Center, China. Electronic address: jeffyah@163.com.

No abstract available

Erratum for

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
Runfeng L, Yunlong H, Jicheng H, Weiqi P, Qinhai M, Yongxia S, Chufang L, Jin Z, Zhenhua J, Haiming J, Kui Z, Shuxiang H, Jun D, Xiaobo L, Xiaotao H, Lin W, Nanshan Z, Zifeng Y. Runfeng L, et al. Pharmacol Res. 2020 Jun;156:104761. doi: 10.1016/j.phrs.2020.104761. Epub 2020 Mar 20. Pharmacol Res. 2020. PMID: 32205232 Free PMC article.